{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:45:23Z","timestamp":1781966723290,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Postgraduate Research and Practice Innovation Program of Jiangsu Province","award":["KYCX23_3617 and SJCX23_2028"],"award-info":[{"award-number":["KYCX23_3617 and SJCX23_2028"]}]},{"name":"the Postgraduate Research and Practice Innovation Program of Jiangsu Province","award":["KYCX23_3617 and SJCX23_2028"],"award-info":[{"award-number":["KYCX23_3617 and SJCX23_2028"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373034 and 82203716"],"award-info":[{"award-number":["82373034 and 82203716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the \u201c13th Five-Year Plan\u201d Science and Education Strong Health Project Innovation Team of Yangzhou","award":["LJRC20181 and YZCXTD201801"],"award-info":[{"award-number":["LJRC20181 and YZCXTD201801"]}]},{"name":"the Provincial-Level Discipline Leader of the NJPH","award":["DTRA202214"],"award-info":[{"award-number":["DTRA202214"]}]},{"name":"the Cross-Cooperation Special Projects of the NJPH","award":["YJCHZ-2021-08"],"award-info":[{"award-number":["YJCHZ-2021-08"]}]},{"name":"the Beiing iGanDan Foundation","award":["GDXZ-08-19"],"award-info":[{"award-number":["GDXZ-08-19"]}]},{"name":"Yangzhou Basic Research Program","award":["2024-3-02"],"award-info":[{"award-number":["2024-3-02"]}]},{"name":"Construction and Clinical Application of Innovative Perioperative Management System for Minimally Invasive Surgery of Hepatic Portal Hypertension in Hepatitis B-related Liver Cirrhosis","award":["K2023002"],"award-info":[{"award-number":["K2023002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02612-9","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:39:30Z","timestamp":1738262370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential"],"prefix":"10.1007","volume":"42","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyuan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dousheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2612_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2612_CR2","doi-asserted-by":"crossref","unstructured":"Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132.","DOI":"10.1002\/hep.24199"},{"key":"2612_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2612_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S, Malik F. Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal. 2024;22:109.","journal-title":"Cell Commun Signal"},{"key":"2612_CR5","doi-asserted-by":"crossref","unstructured":"Cheng A-L, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76:862\u201373.","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"2612_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619\u201326.","journal-title":"J Cell Biol"},{"key":"2612_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73150","volume":"11","author":"D Fanfone","year":"2022","unstructured":"Fanfone D, Wu Z, Mammi J, Berthenet K, Neves D, Weber K, et al. Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness. Elife. 2022;11: e73150.","journal-title":"Elife"},{"key":"2612_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.devcel.2022.05.017","volume":"57","author":"F Macabenta","year":"2022","unstructured":"Macabenta F, Sun H-T, Stathopoulos A. BMP-gated cell-cycle progression drives anoikis during mesenchymal collective migration. Dev Cell. 2022;57:1683-1693.e3.","journal-title":"Dev Cell"},{"key":"2612_CR9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ncb3250","volume":"17","author":"J Alanko","year":"2015","unstructured":"Alanko J, Mai A, Jacquemet G, Schauer K, Kaukonen R, Saari M, et al. Integrin endosomal signalling suppresses anoikis. Nat Cell Biol. 2015;17:1412\u201321.","journal-title":"Nat Cell Biol"},{"key":"2612_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"2612_CR11","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1242\/jcs.072165","volume":"124","author":"MC Guadamillas","year":"2011","unstructured":"Guadamillas MC, Cerezo A, Del Pozo MA. Overcoming anoikis\u2013pathways to anchorage-independent growth in cancer. J Cell Sci. 2011;124:3189\u201397.","journal-title":"J Cell Sci"},{"key":"2612_CR12","doi-asserted-by":"crossref","unstructured":"Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. 2022;","DOI":"10.1007\/s10585-022-10172-9"},{"key":"2612_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12906-018-2083-2","volume":"18","author":"B Hu","year":"2018","unstructured":"Hu B, Zhang T, An H-M, Zheng J-L, Yan X, Huang X-W. Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells. BMC Complement Altern Med. 2018;18:17.","journal-title":"BMC Complement Altern Med"},{"key":"2612_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.molcel.2020.05.014","volume":"78","author":"A Strasser","year":"2020","unstructured":"Strasser A, Vaux DL. Cell Death in the Origin and Treatment of Cancer. Mol Cell. 2020;78:1045\u201354.","journal-title":"Mol Cell"},{"key":"2612_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.","journal-title":"Signal Transduct Target Ther"},{"key":"2612_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"2612_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(00)00003-9","volume":"102","author":"DR Green","year":"2000","unstructured":"Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 2000;102:1\u20134.","journal-title":"Cell"},{"issue":"Pt 1","key":"2612_CR18","first-page":"1","volume":"326","author":"GM Cohen","year":"1997","unstructured":"Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326(Pt 1):1\u201316.","journal-title":"Biochem J"},{"key":"2612_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrm2312","volume":"9","author":"RC Taylor","year":"2008","unstructured":"Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9:231\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2612_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","volume":"296","author":"H Wajant","year":"2002","unstructured":"Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296:1635\u20136.","journal-title":"Science"},{"key":"2612_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/306879","volume":"2012","author":"Y-N Kim","year":"2012","unstructured":"Kim Y-N, Koo KH, Sung JY, Yun U-J, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012: 306879.","journal-title":"Int J Cell Biol"},{"key":"2612_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116878","volume":"176","author":"Y Wang","year":"2024","unstructured":"Wang Y, Fleishman JS, Wang J, Chen J, Zhao L, Ding M. Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma. Biomed Pharmacother. 2024;176: 116878.","journal-title":"Biomed Pharmacother"},{"key":"2612_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.gastro.2012.03.053","volume":"143","author":"J Xu","year":"2012","unstructured":"Xu J, Liu H, Chen L, Wang S, Zhou L, Yun X, et al. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology. 2012;143:199-212.e4.","journal-title":"Gastroenterology"},{"key":"2612_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/cas.12632","volume":"106","author":"X-X Feng","year":"2015","unstructured":"Feng X-X, Luo J, Liu M, Yan W, Zhou Z-Z, Xia Y-J, et al. Sirtuin 6 promotes transforming growth factor-\u03b21\/H2O2\/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence. Cancer Sci. 2015;106:559\u201366.","journal-title":"Cancer Sci"},{"key":"2612_CR25","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1159\/000430292","volume":"36","author":"W Tang","year":"2015","unstructured":"Tang W, Feng X, Zhang S, Ren Z, Liu Y, Yang B, et al. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway. Cell Physiol Biochem. 2015;36:1223\u201336.","journal-title":"Cell Physiol Biochem"},{"key":"2612_CR26","doi-asserted-by":"publisher","first-page":"32523","DOI":"10.18632\/oncotarget.15808","volume":"8","author":"B Sun","year":"2017","unstructured":"Sun B, Hu C, Yang Z, Zhang X, Zhao L, Xiong J, et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget. 2017;8:32523\u201335.","journal-title":"Oncotarget"},{"key":"2612_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626577","volume":"11","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol. 2021;11: 626577.","journal-title":"Front Oncol"},{"key":"2612_CR28","doi-asserted-by":"publisher","first-page":"1367364","DOI":"10.3389\/fonc.2024.1367364","volume":"14","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Cui T, Wei F, Zhou Z, Sun Y, Gao C, et al. Wnt\/\u03b2-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target. Front Oncol. 2024;14:1367364.","journal-title":"Front Oncol"},{"key":"2612_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/hep4.1361","volume":"3","author":"Y Ashizawa","year":"2019","unstructured":"Ashizawa Y, Kuboki S, Nojima H, Yoshitomi H, Furukawa K, Takayashiki T, et al. OLFM4 enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma. Hepatol Commun. 2019;3:954\u201370.","journal-title":"Hepatol Commun"},{"key":"2612_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/15384047.2022.2035629","volume":"23","author":"G Wang","year":"2022","unstructured":"Wang G, Zhou X, Guo Z, Huang N, Li J, Lv Y, et al. The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-\u03b2. Cancer Biol Ther. 2022;23:150\u201362.","journal-title":"Cancer Biol Ther"},{"key":"2612_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079857","volume":"8","author":"X-X Feng","year":"2013","unstructured":"Feng X-X, Liu M, Yan W, Zhou Z-Z, Xia Y-J, Tu W, et al. \u03b23 Integrin Promotes TGF-\u03b21\/H2O2\/HOCl-Mediated Induction of Metastatic Phenotype of Hepatocellular Carcinoma Cells by Enhancing TGF-\u03b21 Signaling. PLoS ONE. 2013;8: e79857.","journal-title":"PLoS ONE"},{"key":"2612_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101606","volume":"59","author":"M Ashrafizadeh","year":"2022","unstructured":"Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, et al. Non-coding RNA-based regulation of inflammation. Semin Immunol. 2022;59: 101606.","journal-title":"Semin Immunol"},{"key":"2612_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.canlet.2017.10.012","volume":"412","author":"X-T Fu","year":"2018","unstructured":"Fu X-T, Shi Y-H, Zhou J, Peng Y-F, Liu W-R, Shi G-M, et al. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 2018;412:108\u201317.","journal-title":"Cancer Lett"},{"key":"2612_CR34","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.7150\/jca.51849","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang S, Lv Y, Zhou Y, Ling J, Wang H, Gu D, et al. Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p. J Cancer. 2021;12:3418\u201326.","journal-title":"J Cancer"},{"key":"2612_CR35","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.18632\/oncotarget.2956","volume":"6","author":"X Zhang","year":"2014","unstructured":"Zhang X, Cheng S-L, Bian K, Wang L, Zhang X, Yan B, et al. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. Oncotarget. 2014;6:2277\u201389.","journal-title":"Oncotarget"},{"key":"2612_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.31083\/j.fbl2902076","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Hu Y, Zhao K, Fan J, Zhu J, Li Q, et al. Comprehensive analysis of the expression of cell adhesion molecules genes in hepatocellular carcinoma and their prognosis, and biological significance. Front Biosci (Landmark Ed). 2024;29:76.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2612_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jss.2014.09.031","volume":"194","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liang B, Guan Y, You J, Zhu L, Chen X, et al. Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma. J Surg Res. 2015;194:167\u201376.","journal-title":"J Surg Res"},{"key":"2612_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111378","volume":"124","author":"K-J Lv","year":"2024","unstructured":"Lv K-J, Yu S-Z, Wang Y, Zhang S-R, Li W-Y, Hou J, et al. Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1. Cell Signal. 2024;124: 111378.","journal-title":"Cell Signal"},{"key":"2612_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.7150\/thno.51646","volume":"11","author":"J Song","year":"2021","unstructured":"Song J, Liu Y, Liu F, Zhang L, Li G, Yuan C, et al. The 14-3-3\u03c3 protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1\/2 signaling pathway. Theranostics. 2021;11:996\u20131015.","journal-title":"Theranostics"},{"key":"2612_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174271","volume":"12","author":"M Lee","year":"2017","unstructured":"Lee M, Jo A, Lee S, Kim JB, Chang Y, Nam JY, et al. 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells. PLoS ONE. 2017;12: e0174271.","journal-title":"PLoS ONE"},{"key":"2612_CR41","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbrc.2016.04.049","volume":"473","author":"S Lee","year":"2016","unstructured":"Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, et al. 17\u03b2-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6\/STAT3 signaling. Biochem Biophys Res Commun. 2016;473:1247\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"2612_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tiv.2018.09.003","volume":"53","author":"B Wudtiwai","year":"2018","unstructured":"Wudtiwai B, Pitchakarn P, Banjerdpongchai R. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. Toxicol In Vitro. 2018;53:222\u201332.","journal-title":"Toxicol In Vitro"},{"key":"2612_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1476-4598-9-126","volume":"9","author":"H-L Cheng","year":"2010","unstructured":"Cheng H-L, Su S-J, Huang L-W, Hsieh B-S, Hu Y-C, Hung T-C, et al. Arecoline induces HA22T\/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation. Mol Cancer. 2010;9:126.","journal-title":"Mol Cancer"},{"key":"2612_CR44","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1038\/s41598-020-64603-2","volume":"10","author":"W-C Lim","year":"2020","unstructured":"Lim W-C, Kim H, Kim Y-J, Jeon B-N, Kang H-B, Ko H. Catechol inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition and stem cell-like properties in hepatocellular carcinoma cells. Sci Rep. 2020;10:7620.","journal-title":"Sci Rep"},{"key":"2612_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1476-4598-13-226","volume":"13","author":"M-X Feng","year":"2014","unstructured":"Feng M-X, Ma M-Z, Fu Y, Li J, Wang T, Xue F, et al. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Mol Cancer. 2014;13:226.","journal-title":"Mol Cancer"},{"key":"2612_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22089","volume":"9","author":"Z Han","year":"2023","unstructured":"Han Z, Huang Q, Lv M, Ma M, Zhang W, Feng W, et al. Qizhu Anti-Cancer Recipe promotes anoikis of hepatocellular carcinoma cells by activating the c-Jun N-terminal kinase pathway. Heliyon. 2023;9: e22089.","journal-title":"Heliyon"},{"key":"2612_CR47","doi-asserted-by":"publisher","first-page":"607675","DOI":"10.1155\/2012\/607675","volume":"2012","author":"B Hu","year":"2012","unstructured":"Hu B, An H-M, Shen K-P, Song H-Y, Deng S. Polygonum cuspidatum extract induces anoikis in hepatocarcinoma cells associated with generation of reactive oxygen species and downregulation of focal adhesion kinase. Evid Based Complement Alternat Med. 2012;2012:607675.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2612_CR48","first-page":"491","volume":"15","author":"X Zhang","year":"2016","unstructured":"Zhang X, Yu H. Matrine inhibits diethylnitrosamine-induced HCC proliferation in rats through inducing apoptosis via p53, Bax-dependent caspase-3 activation pathway and down-regulating MLCK overexpression. Iran J Pharm Res. 2016;15:491\u20139.","journal-title":"Iran J Pharm Res"},{"key":"2612_CR49","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/0008-5472.CAN-04-3037","volume":"65","author":"KL Schaefer","year":"2005","unstructured":"Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, et al. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells. Cancer Res. 2005;65:2251\u20139.","journal-title":"Cancer Res"},{"key":"2612_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.taap.2011.11.001","volume":"258","author":"L-W Huang","year":"2012","unstructured":"Huang L-W, Hsieh B-S, Cheng H-L, Hu Y-C, Chang W-T, Chang K-L. Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol Appl Pharmacol. 2012;258:199\u2013207.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2612_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100372","volume":"9","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Deng H, Yan W, Luo M, Tu W, Xia Y, et al. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells. PLoS ONE. 2014;9: e100372.","journal-title":"PLoS ONE"},{"key":"2612_CR52","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/biomedicines9111639","volume":"9","author":"EJ Sun","year":"2021","unstructured":"Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L. Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Biomedicines. 2021;9:1639.","journal-title":"Biomedicines"},{"key":"2612_CR53","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1078-0432.CCR-09-1015","volume":"16","author":"A Mancino","year":"2010","unstructured":"Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res. 2010;16:784\u20139.","journal-title":"Clin Cancer Res"},{"key":"2612_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.755856","volume":"12","author":"EY Bassoy","year":"2021","unstructured":"Bassoy EY, Walch M, Martinvalet D. Reactive oxygen species: do they play a role in adaptive immunity? Front Immunol. 2021;12: 755856.","journal-title":"Front Immunol"},{"key":"2612_CR55","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/2159-8290.CD-20-1209","volume":"11","author":"TA Yap","year":"2021","unstructured":"Yap TA, Parkes EE, Peng W, Moyers JT, Curran MA, Tawbi HA. Development of immunotherapy combination strategies in cancer. Cancer Discov. 2021;11:1368\u201397.","journal-title":"Cancer Discov"},{"key":"2612_CR56","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/hep.30337","volume":"69","author":"MJ Flynn","year":"2019","unstructured":"Flynn MJ, Sayed AA, Sharma R, Siddique A, Pinato DJ. Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma. Hepatology. 2019;69:2258\u201370.","journal-title":"Hepatology"},{"key":"2612_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104723","volume":"106","author":"B Li","year":"2020","unstructured":"Li B, Ren M, Zhou X, Han Q, Cheng L. Targeting tumor-associated macrophages in head and neck squamous cell carcinoma. Oral Oncol. 2020;106: 104723.","journal-title":"Oral Oncol"},{"key":"2612_CR58","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.humimm.2019.03.014","volume":"80","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Nafady-Hego H, Mansor SG, Abbas WA, Abdel-Malek MO, Mekky MA, et al. Increased frequency and FOXP3 expression of human CD8(+)CD25(High+) T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Hum Immunol. 2019;80:510\u20136.","journal-title":"Hum Immunol"},{"key":"2612_CR59","first-page":"45","volume":"25","author":"AM Zahran","year":"2018","unstructured":"Zahran AM, Abdel-Meguid MM, Ashmawy AM, Rayan A, Elkady A, Elsherbiny NM, et al. Frequency and implications of natural killer and natural killer t cells in hepatocellular carcinoma. Egypt J Immunol. 2018;25:45\u201352.","journal-title":"Egypt J Immunol"},{"key":"2612_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.25397","volume":"128","author":"F Shi","year":"2011","unstructured":"Shi F, Shi M, Zeng Z, Qi R-Z, Liu Z-W, Zhang J-Y, et al. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer. 2011;128:887\u201396.","journal-title":"Int J Cancer"},{"key":"2612_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u20137.","journal-title":"Nature"},{"key":"2612_CR62","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2612_CR63","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/ijms24032862","volume":"24","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang W, Ouyang J, Wang J, Xie Z. Identification of anoikis-related subgroups and prognosis model in liver hepatocellular carcinoma. Int J Mol Sci. 2023;24:2862.","journal-title":"Int J Mol Sci"},{"key":"2612_CR64","doi-asserted-by":"publisher","first-page":"47195","DOI":"10.18632\/oncotarget.17587","volume":"8","author":"Y-F Yang","year":"2017","unstructured":"Yang Y-F, Pan Y-H, Cao Y, Fu J, Yang X, Zhang M-F, et al. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of \u03b2-Catenin signaling in hepatocellular carcinoma. Oncotarget. 2017;8:47195\u2013205.","journal-title":"Oncotarget"},{"key":"2612_CR65","doi-asserted-by":"crossref","unstructured":"Han J, An O, Hong H, Chan THM, Song Y, Shen H, et al. Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression. Sci Adv. 2020;6:eaba5136.","DOI":"10.1126\/sciadv.aba5136"},{"key":"2612_CR66","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.18632\/aging.205438","volume":"16","author":"T Wang","year":"2024","unstructured":"Wang T, Guo K, Yang S, Zhang D, Cui H, Yin J, et al. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features. Aging (Albany NY). 2024;16:1440.","journal-title":"Aging (Albany NY)"},{"key":"2612_CR67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/CAD.0000000000001589","volume":"35","author":"J Zhu","year":"2024","unstructured":"Zhu J, Zhao W, Yang J, Liu C, Wang Y, Zhao H. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Anticancer Drugs. 2024;35:466.","journal-title":"Anticancer Drugs"},{"key":"2612_CR68","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/03009858211005537","volume":"58","author":"SF Santagostino","year":"2021","unstructured":"Santagostino SF, Assenmacher C-A, Tarrant JC, Adedeji AO, Radaelli E. Mechanisms of regulated cell death: current perspectives. Vet Pathol. 2021;58:596\u2013623.","journal-title":"Vet Pathol"},{"key":"2612_CR69","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41575-019-0179-x","volume":"16","author":"J Bruix","year":"2019","unstructured":"Bruix J, da Fonseca LG, Reig M. Insights into the success and failure of systemic therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2019;16:617\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2612_CR70","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc3789","volume":"14","author":"CL Buchheit","year":"2014","unstructured":"Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14:632\u201341.","journal-title":"Nat Rev Cancer"},{"key":"2612_CR71","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1111\/cas.14411","volume":"111","author":"Y Takagi","year":"2020","unstructured":"Takagi Y, Sakai N, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, et al. High expression of Kr\u00fcppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer. Cancer Sci. 2020;111:2078\u201392.","journal-title":"Cancer Sci"},{"key":"2612_CR72","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/cas.14320","volume":"111","author":"M Shimokawa","year":"2020","unstructured":"Shimokawa M, Yoshizumi T, Itoh S, Iseda N, Sakata K, Yugawa K, et al. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Cancer Sci. 2020;111:1228\u201340.","journal-title":"Cancer Sci"},{"key":"2612_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101402","volume":"20","author":"EY Kim","year":"2022","unstructured":"Kim EY, Cha YJ, Jeong S, Chang YS. Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas. Transl Oncol. 2022;20: 101402.","journal-title":"Transl Oncol"},{"key":"2612_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148867","volume":"931","author":"ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma","year":"2024","unstructured":"ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma. Gene. 2024;931: 148867.","journal-title":"Gene"},{"key":"2612_CR75","unstructured":"Khan SU, Fatima K, Malik F, Wani A. Cancer metastasis: Molecular mechanisms and clinical perspectives."},{"key":"2612_CR76","doi-asserted-by":"publisher","unstructured":"Jan S, Fatima K, Malik F, Wani A, Khan SU. Introduction to Drug Resistance in Cancer. In: Khan SU, Malik F, editors. Drug Resistance in Cancer: Mechanisms and Strategies. Singapore: Springer Nature Singapore; 2024. p. 1\u201330. Available from: https:\/\/doi.org\/10.1007\/978-981-97-1666-1_1","DOI":"10.1007\/978-981-97-1666-1_1"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02612-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:27:40Z","timestamp":1741271260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02612-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"58"}}